Donate
News + Publications
Careers
Donate
Contact
Back
Who
We Are
Board of Directors + Governance
Our Leadership
Our Team
Our Partners
Our Benefactors
Our History
Health Impact Reports
Our
Programs
All Programs
Accelerating Medicines Partnership® (AMP®)
Accelerating COVID-19 Therapeutic Interventions & Vaccines (ACTIV)
Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Biomarkers Consortium
GeneConvene Global Collaborative
Azithromycin Prevention in Labor Use Study (A-PLUS)
Master Protocol for Treatment of Non-Small Cell Lung Cancer (Lung-MAP)
Partnership For Accelerating Cancer Therapies (PACT)
Edmond J. Safra Family Lodge
Global Pandemic Treaty
All of Us Research Program
Education & Training Programs
Fighting
Diseases
All Disease
Cancer
Cardiovascular
Infectious Diseases
Inflammation + Immunology
Maternal, Child + Newborn Health
Metabolic Disorders
Neurological Diseases
Rare Diseases
Powering
Science
The Lurie Prize in Biomedical Sciences
Trailblazer Prize for Clinician-Scientists
Charles A. Sanders, MD Partnership Award
The Deeda Blair Research Initiative for Disorders of the Brain
Research Support
Fellowships & Training
Lectures
Patient
Voices
Donate
Partner With Us
News
News
Publications
Social Media
Newsletters
Home
News
May 22, 2023
The Foundation for the National Institutes of Health announces the appointment of Jay Bradner, M.D. and Jim Weiss to the board of the directors
FNIH Press Release
May 16, 2023
The Foundation for the National Institutes of Health Announces Selection of Eight Rare Diseases for the Bespoke Gene Therapy Consortium Clinical Trial Portfolio
FNIH Press Release
April 4, 2023
Cell Metabolism Features the AMP® Type 2 Diabetes Knowledge Portal as a Valuable Tool for Biomedical Researchers
FNIH Press Release
February 9, 2023
The FNIH Announces Results of a New Study Published in The New England Journal of Medicine Showing a Single Dose of Azithromycin Reduced Maternal Sepsis by 35%
January 31, 2023
FNIH Announces Second Round of Awards by the Deeda Blair Research Initiative for Disorders of the Brain
January 10, 2023
Accelerated Approval Not the Finish Line, Says FDA Commissioner
MedPage Today
December 29, 2022
Ambitious NCATS Bespoke Gene Therapy Consortium Targets Ultrarare Diseases
RareDiseaseAdvisor
December 1, 2022
Announcing the NCBI SARS-CoV-2 Variant Calling Pipeline and Related Data Products
NLM NCBI Insights
Show More
Partner With Us
Work with the FNIH to accelerate medical breakthroughs for patients
Let's Collaborate